[HTML][HTML] Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series
C Zhang, J Gu, Q Chen, N Deng, J Li, L Huang… - PLoS …, 2020 - journals.plos.org
Background As of April 18, 2020, over 2,000,000 patients had been diagnosed with coronavirus
disease-2019 (COVID-19) globally, and more than 140,000 deaths had been reported. …
disease-2019 (COVID-19) globally, and more than 140,000 deaths had been reported. …
A randomized, placebo-controlled trial of human umbilical cord blood mesenchymal stem cell infusion for children with cerebral palsy
L Huang, C Zhang, J Gu, W Wu, Z Shen… - Cell …, 2018 - journals.sagepub.com
Cerebral palsy (CP) is a common disability which results in permanent chronic motor disability
appearing in early childhood. Recently human umbilical cord blood mesenchymal stem …
appearing in early childhood. Recently human umbilical cord blood mesenchymal stem …
[HTML][HTML] Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial
J Gu, L Huang, C Zhang, Y Wang, R Zhang… - Stem Cell Research & …, 2020 - Springer
Background Cerebral palsy (CP) is a syndrome of childhood movement and posture disorders.
Clinical evidence is still limited and sometimes inconclusive about the benefits of human …
Clinical evidence is still limited and sometimes inconclusive about the benefits of human …
Clinical characteristics of 34 children with coronavirus disease-2019 in the west of China: a multiple-center case series
C Zhang, J Gu, Q Chen, NA Deng, J Li, L Huang… - MedRxiv, 2020 - medrxiv.org
Background Up to 9 March, 2020, 109577 patients were diagnosed with coronavirus
disease-2019 (COVID-19) globally. The clinical and epidemiological characteristics of adult …
disease-2019 (COVID-19) globally. The clinical and epidemiological characteristics of adult …
Therapy for cerebral palsy by human umbilical cord blood mesenchymal stem cells transplantation combined with basic rehabilitation treatment: a case report
C Zhang, L Huang, J Gu, X Zhou - Global Pediatric Health, 2015 - journals.sagepub.com
Background. Cerebral palsy (CP) is the most common cause leading to childhood disability.
Human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) transplantation is a …
Human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) transplantation is a …
Nr2e1 deficiency aggravates insulin resistance and chronic inflammation of visceral adipose tissues in a diet-induced obese mice model
G He, J Gu, H Wang, S Cheng, Q Xiong, M Ke, Y Hu… - Life Sciences, 2021 - Elsevier
Aims To investigate the nuclear receptor subfamily 2 group E member 1 (Nr2e1) expression
in adipose tissues of obese mice and assess the role of Nr2e1 in insulin resistance and …
in adipose tissues of obese mice and assess the role of Nr2e1 in insulin resistance and …
[HTML][HTML] Metabolic assessment of cerebral palsy with normal clinical MRI using 18F-FDG PET imaging: A preliminary report
…, Y Chen, F Tan, D Zeng, H Wan, Y Yang, J Gu… - Frontiers in …, 2022 - frontiersin.org
To explore the cerebral metabolic patterns of cerebral palsy (CP) patients without structural
abnormalities by brain magnetic resonance imaging (MRI) scans, we evaluated 18 F-fluoro-…
abnormalities by brain magnetic resonance imaging (MRI) scans, we evaluated 18 F-fluoro-…
[HTML][HTML] Effects of public health interventions and zero COVID policy on paediatric diseases: A Southern China study
L Huang, C Yang, H Pan, Y Gu, L Li, M Kou… - Journal of Global …, 2024 - ncbi.nlm.nih.gov
Background With the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in schools and communities, clinical evidence is needed to determine the …
pandemic in schools and communities, clinical evidence is needed to determine the …
Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China
L Huang, J Zou, Y Zhang, J Gu, J Wu, C Zhang - BMJ open, 2024 - bmjopen.bmj.com
Introduction Alport syndrome (AS) is one of the most common fatal hereditary renal diseases
in human, with a high risk of progressing to end-stage renal disease without effective …
in human, with a high risk of progressing to end-stage renal disease without effective …
[HTML][HTML] Protocol: Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China
L Huang, J Zou, Y Zhang, J Gu, J Wu, C Zhang - BMJ Open, 2024 - ncbi.nlm.nih.gov
Introduction Alport syndrome (AS) is one of the most common fatal hereditary renal diseases
in human, with a high risk of progressing to end-stage renal disease without effective …
in human, with a high risk of progressing to end-stage renal disease without effective …